Cargando…
LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914340/ https://www.ncbi.nlm.nih.gov/pubmed/26910840 http://dx.doi.org/10.18632/oncotarget.7509 |
_version_ | 1782438547232391168 |
---|---|
author | Lv, Mingming Xu, Pengfei Wu, Ying Huang, Lei Li, Wenqu Lv, Shanshan Wu, Xiaowei Zeng, Xin Shen, Rong Jia, Xuemei Yin, Yongmei Gu, Yun Yuan, Hongyan Xie, Hui Fu, Ziyi |
author_facet | Lv, Mingming Xu, Pengfei Wu, Ying Huang, Lei Li, Wenqu Lv, Shanshan Wu, Xiaowei Zeng, Xin Shen, Rong Jia, Xuemei Yin, Yongmei Gu, Yun Yuan, Hongyan Xie, Hui Fu, Ziyi |
author_sort | Lv, Mingming |
collection | PubMed |
description | Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in the post-genome period, long non-coding RNAs (lncRNAs) have been found to play critical roles in many cancers, including TNBC. However, there is little information on differentially expressed lncRNAs between TNBC and non-TNBC. We detected the expression levels of lncRNAs in TNBC and non-TNBC tissues separately. Then we analyzed the lncRNA expression signature of TNBC relative to non-TNBC, and found dysregulated lncRNAs participated in important biological processes though Gene Ontology and Pathway analysis. Finally, we validated these lncRNA expression levels in breast cancer tissues and cells, and then confirmed that 4 lncRNAs (RP11-434D9.1, LINC00052, BC016831, and IGKV) were correlated with TNBC occurrence through receiver operating characteristic curve analysis. This study offers helpful information to understand the initiation and development mechanisms of TNBC comprehensively and suggests potential biomarkers for diagnosis or therapy targets for clinical treatment. |
format | Online Article Text |
id | pubmed-4914340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49143402016-07-11 LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer Lv, Mingming Xu, Pengfei Wu, Ying Huang, Lei Li, Wenqu Lv, Shanshan Wu, Xiaowei Zeng, Xin Shen, Rong Jia, Xuemei Yin, Yongmei Gu, Yun Yuan, Hongyan Xie, Hui Fu, Ziyi Oncotarget Research Paper Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in the post-genome period, long non-coding RNAs (lncRNAs) have been found to play critical roles in many cancers, including TNBC. However, there is little information on differentially expressed lncRNAs between TNBC and non-TNBC. We detected the expression levels of lncRNAs in TNBC and non-TNBC tissues separately. Then we analyzed the lncRNA expression signature of TNBC relative to non-TNBC, and found dysregulated lncRNAs participated in important biological processes though Gene Ontology and Pathway analysis. Finally, we validated these lncRNA expression levels in breast cancer tissues and cells, and then confirmed that 4 lncRNAs (RP11-434D9.1, LINC00052, BC016831, and IGKV) were correlated with TNBC occurrence through receiver operating characteristic curve analysis. This study offers helpful information to understand the initiation and development mechanisms of TNBC comprehensively and suggests potential biomarkers for diagnosis or therapy targets for clinical treatment. Impact Journals LLC 2016-02-19 /pmc/articles/PMC4914340/ /pubmed/26910840 http://dx.doi.org/10.18632/oncotarget.7509 Text en Copyright: © 2016 Lv et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Lv, Mingming Xu, Pengfei Wu, Ying Huang, Lei Li, Wenqu Lv, Shanshan Wu, Xiaowei Zeng, Xin Shen, Rong Jia, Xuemei Yin, Yongmei Gu, Yun Yuan, Hongyan Xie, Hui Fu, Ziyi LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title_full | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title_fullStr | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title_full_unstemmed | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title_short | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
title_sort | lncrnas as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914340/ https://www.ncbi.nlm.nih.gov/pubmed/26910840 http://dx.doi.org/10.18632/oncotarget.7509 |
work_keys_str_mv | AT lvmingming lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT xupengfei lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT wuying lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT huanglei lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT liwenqu lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT lvshanshan lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT wuxiaowei lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT zengxin lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT shenrong lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT jiaxuemei lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT yinyongmei lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT guyun lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT yuanhongyan lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT xiehui lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer AT fuziyi lncrnasasnewbiomarkerstodifferentiatetriplenegativebreastcancerfromnontriplenegativebreastcancer |